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Abstract.  Growth factor over-production by responsive 
cells might contribute to their autonomous prolifera- 
tion as well as their acquisition of a  transformed 
phenotype in culture.  Basic fibroblast growth factor 
(bFGF) has been shown to induce transient changes in 
cell behavior that resemble those encountered in trans- 
formed cells.  In addition,  several types of human tu- 
mor cells have been shown to produce bFGE  To de- 
termine directly the role that bFGF might play in the 
induction of the transformed phenotype, we have intro- 
duced a  human bFGF cDNA expression vector into 
baby hamster kidney-derived (BHK-21) fibroblasts. 
One of the BHK transfectants, termed clone  19,  ex- 
presses the bFGF mRNA and produces biologically 
active bFGF that accumulates to a  high concentration 
inside the cells.  These properties correlate with the 
ability of the cells to grow in serum-free medium 
without the addition of exogenous bFGE  Clone  19 
cells also proliferated in soft agar,  indicating that con- 
stitutive expression of the bFGF gene results  in a  loss 
of anchorage-dependent growth. 
B 
ASXC fibroblast  growth  factor  (bFGF) ~ is  a  potent 
broad spectrum mitogen that in bovine and human 
cells is  encoded by 3.7- and 7.0-kb  mRNA  species 
(1, 6). This mitogen appears to be synthesized initially as a 
155 residue protein, which can be further processed through 
proteolytic cleavage of its  amino-terminal region into two 
shorter forms (146 and 131 residues), which are as active as 
the native form (ll). bFGF is structurally related to acidic 
fibroblast growth factor (aFGF) (7), and both growth factors 
interact  with  the  same  cell  surface  receptors  (29).  Both 
growth factors trigger a  similar range of biological effects, 
but differential activities are apparent.  For example, bFGF 
induces the proliferation and  differentiation of responsive 
cells with a much stronger potency 04). In vivo, as well as 
in vitro, both peptides act as potent mitogens and morpho- 
gens  for a  similar  wide  variety of neuroectodermal- and 
mesenchymal-derived cells  (14), including  vascular endo- 
thelial cells (13, 16,  17). Recent studies indicate that in vivo, 
bFGF mimics the effect of the vegetalizing factor, which is 
responsible in early embryos (Xenopus laevis, stage 8 blastu- 
lae) for the formation of mesenchyme from the animal pole 
1. Abbreviations  used in this paper:  ACE,  bovine adrenal  cortex-derived 
capillary endothelial cells; aFGF, acidic fibroblast growth factor; bFGF, ba- 
sic fibroblast  growth factor; BHK-21, baby hamster kidney cell line clone 
21; CS, calf serum; DF medium, a  1:1 mixture of DME and F-12 media; 
GM-CSF, granulocyte-macrophage colony stimulating  factor; HDL, high- 
density lipoproteins;  HS, heparin-Sepharose; MTT, dimethylthiazol  diphe- 
nyltetrazolium  bromide;  PDGF,  platelet-derived  growth  factor;  TGFB, 
transforming growth factor beta. 
(42). It therefore appears that in vivo, FGF can instruct cells 
that are destined to differentiate into ectoderm to form mes- 
enchymal tissue instead. 
Early  studies  have  also  shown  that  in  addition  to  its 
proliferative  and  differentiative  effect  on  normal  diploid 
cells, bFGF could also induce phenotypic changes resem- 
bling  those  encountered  in  transformed  cells.  It  induces 
density-inhibited monolayers of BALB/c 3T3 cells grown to 
confluence in the presence of serum to resume proliferation 
and to form multiple cell layers (12). It also stimulates the 
growth in soft agar of some established cell lines (34) and 
potentiates  the  effect of transforming  growth  factor  beta 
(TGFB)  (35).  Recent  studies  have  indicated  that  various 
cells derived from  solid  human  tumors,  such  as  rhabdo- 
myosarcomas,  which  are  derived  from  bFGF-responsive 
myoblasts, express high bFGF levels (40). The significance 
of high concentrations of bFGF in tumor cells is presently 
unknown, but could relate to the in vivo angiogenic activity 
of this factor, which would result in increased tumor vas- 
cularization;  additionally,  bFGF  could  contribute  to  the 
growth of tumor cells by stimulating their proliferation. 
The concept of autocrine stimulation of cell proliferation 
postulates that normal diploid cells can gain growth auton- 
omy by acquiring the ability to produce, secrete, and respond 
to a given growth factor (45,  48). Verification of the auto- 
crine hypothesis, in the case of bFGF, requires the demon- 
stration that expression of an introduced bFGF gene in cells 
that do not express this gene, but have functional bFGF cell 
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possibly, in the expression of a transformed phenotype. 
To determine  whether  bFGF  could  act as  an  autocrine 
growth factor, we have introduced a plasmid that directs con- 
stitutive bFGF synthesis into baby hamster kidney cell line 
clone 21 (BHK-21) cells. Expression ofbFGF resulted in au- 
tonomous cell growth and a loss of anchorage dependence 
for growth, as indicated by the ability of the transfected cells 
to grow in serum-free medium and to form colonies in soft 
agar. 
Materials and Methods 
Materials 
Tissue culture media and Geneticin  (G-418  sulfate) were  obtained  from 
Gibco (Grand Island, NY). Saline containing 0.05 % trypsin, 0.01 M sodium 
phosphate (pH  7.4),  and 0.02%  EDTA  (STV)  was obtained  from Difco 
Laboratories Inc. (Detroit, MI). Calf serum (CS) was purchased from Hy- 
Clone Laboratories (Logan, UT), Gentamicin was from Schering (Kenil- 
worth, N J) and Fungizone was from E. R. Squibb (Princeton, N J). Tissue 
culture dishes (96-,  48-,  and 24-well clusters, 35-mm, 5-cm, and  10-cm 
dishes)  were  obtained  from  Falcon  Labware  (Oxnard,  CA).  530-cm  2 
dishes were from Nunc (Applied Scientific, San Francisco, CA). Nitrocellu- 
lose filters were purchased from Schleicher &  Schuell, Inc. (Keene, NH) 
and  molecular size markers for  Northern blots from Bethesda Research 
Laboratories (Gaithersburg, MD). Poly-L-lysine, dimethylthiazol diphenyl- 
tetrazolium bromide (MTT), Ponceau red, transferrin, and gelatin were ob- 
tained from Sigma Chemical Co. (St. Louis, MO). Heparin-Sepharose was 
purchased from Pharmacia Fine Chemicals (Piscataway,  N J).  Agar (150 
mesh) was  purchased  from Calbiochem-Behring Corp.  (La Jolla,  CA). 
Bovine pituitary-derived bFGF and brain-derived aFGF were isolated as 
previously described (11, 18), and the homogeneity of both factors was deter- 
mined  by  SDS-PAGE,  amino  acid  composition,  and  NH2-terminal  se- 
quence analysis of the molecules (18). 1251-bFGF was prepared as described 
(28).  Rabbit anti-bFGF polyclonal antibodies were prepared as previously 
described  (39).  Avidin-alkaline phosphatase and  biotinylated  goat  anti- 
rabbit IgG were obtained from Vector Laboratories, Inc. (Burlingame, CA), 
and 5-bromo-4-chloro-3-indol phosphate and nitro-blue-tetrazolium from 
Kirkegaard & Perry Laboratories, Inc. (Gaithersburg, MD). Human high- 
density lipoproteins (HDL,  1.07 < d <  1.21 g/cm  s) were obtained from hu- 
man plasma by differential ultracentrifugal flotation as previously described 
(10). The plasmid pSV2neo (44), and the plasmid pUC9-MTI8, which con- 
sists of a 3.2-kb Hind III fragment spanning the human metallothionein IIA 
gene (22) cloned into the Hind  Ill site of pUC9, were obtained from the 
plasmid collection of California Biotechnology Inc. (Mountain View, CA). 
Construction of a bFGF Expression  Plasmid (pbFGF) 
For the expression of basic FGF in the BHK cells, a 503-bp fragment encod- 
ing the proposed  155-residue primary translation product of human basic 
FGF (2) was ligated to the human metallothionein IIA promoter, essentially 
as has been described previously for the expression of other proteins (8,  19). 
A 620-bp Sma I-Eco RI fragment from the 3' end of the human growth hor- 
mone gene (41) was then ligated 3' to the basic FGF sequence, to provide 
transcription  termination/polyadenylation signals.  Finally,  the  construct 
was ligated into a derivative of pUC8 carrying the SV-40 origin of replica- 
tion and enhancer sequences (19; see Fig. 1). The details of this construction 
will be described elsewhere (Mitchell, R., J.  Whang, S.  Silver, C. Corer, 
J.  Fiddes, and J.  Abraham, manuscript in preparation). 
Transfection of BHK-21 cells 
Subconfluent BHK-21  cells (1  x  106 cells) grown in 10-cm dishes contain- 
ing  10 ml of a  1:1  (vol/vol) mixture of DME and Ham's F-12 media sup- 
plemented with 50 I.tg/ml Gentamicin, 0.25 ~tg/ml Fungizone, and 5% CS 
(DF medium  +  5%  CS),  were co-transfected with  100 lag of pbFGF,  20 
~g of pUC9-MT18,  and  5  I-tg of pSV2neo (44)  as a  calcium phosphate 
precipitate (51). Control cultures were similarly co-transfected with 20 lsg 
of pUC9-MT18 and 5 ~tg of pSV2neo. Cells were incubated for 6 h at 37~ 
and shocked with glycerol (51).  The medium was then changed and cells 
were grown for 24 h in DF medium supplemented with 5% CS. The cells 
were then incubated in DF medium supplemented with 5%  CS and 570 
~g/ml Geneticin (G-418).  Antibiotic resistant clones were visible after 2 wk 
in selective medium. The clones from the pbFGF transfection (80 clones) 
or the control transfection (148 clones) were trypsinized, pooled, and grown 
to  confluence.  The  pooled  clones  from  pbFGF-transfected  or  control- 
transfected cultures were then tested for their ability to grow in serum-free 
medium. At this stage, only pbFGF transfected cells were able to proliferate 
under serum-free conditions. 
Geneticin-resistant cells  from  pbFGF  transfected  cultures  were  then 
seeded at limiting dilution into 96-well plates in DF medium supplemented 
with 5%  CS. After 10 d 30%  of the wells contained colonies. Cells from 
each well were trypsinized, the cell suspension spun down, and the cell pel- 
let resuspended in DF medium supplemented with 5 lag/ml transferrin, 20 
~tM ZnSO4, and 250 ~tg/ml  HDL (SF  medium) (31).  Cells from each of 
the clones (2  x  104 cells/well) were then seeded in 24-well gelatin-coated 
tissue culture clusters. After 6  d  in culture, actively proliferating clones 
were amplified in SF medium. 
Cell Growth Assays 
Stock cultures of bovine adrenal cortex-derived capillary endothelial cells 
(ACE  cells)  were  cultured  as  previously  described  (16) in  DME  sup- 
plemented with 50 p_g/ml Gentamicin, 0.25 p.g/ml Fungizone, and 10% CS. 
The cultures received 1 ng/ml bFGF until they became confluent. For pas- 
saging, confluent cultures were washed once with PBS and then exposed 
(2-3 rain, 24~  to STV. Rounded cells were then suspended in DME sup- 
plemented with 10% CS. Cell density was determined by counting an aliquot 
in a Coulter Counter (Coulter Electronic,  Inc., Hialeah,  FL).  Cells were 
then seeded at the various densities indicated in the figure legends. 
Stock cultures of BHK-21  cells and BHK-21 transfectants were grown in 
DF medium supplemented with 5 % CS. For passaging, confluent cultures 
were trypsinized as described above, and cells were resuspended in either 
DF medium supplemented with 5%  CS,  or,  in the case of BHK-21  cells 
grown in serum-free medium, DF  medium supplemented with 2  mg/ml 
BSA. In the latter case, the cells were then spun down and the cell pellet 
was resuspended in DF medium supplemented with 5 p.g/ml transferrin, 20 
~M ZnSO4, and 250 ~g/ml HDL (31). Aliquots containing the appropriate 
cell  number were seeded onto 35-mm gelatinized tissue culture dishes. 
For cell growth assays, cells were seeded into gelatin-coated or noncoated 
35-mm dishes containing the appropriate medium as described in the figure 
legends. Cultures were maintained in a humidified incubator (37~  in a 5 % 
CO2/95%  air environment for BHK-21  cells and  10%  CO2/90%  air envi- 
ronment for ACE cells. To determine plating efficiency,  duplicate cultures 
were trypsinized 6 h later and cells counted. Pituitary-derived bFGF or sam- 
ples to be tested were added every other day.  After various time intervals, 
cultures were trypsinized and cell densities were determined with a Coulter 
Counter. 
FGF  Purification from Crude Cell Extracts 
For large scale culture of BHK-21  cells, 6  ￿  106 cells were seeded in 530- 
cm  2 tissue culture plates containing 120 ml of DF medium supplemented 
with  5%  CS.  Once cultures were  confluent,  cells were  trypsinized and 
resuspended in STV.  After the addition of calf serum (5%) to neutralize 
trypsin, the cell suspension was centrifuged (300 g, 5 min). The cell pellet 
was then resuspended in PBS and centrifuged (300 g, 5 min). The cell pellet 
was either extracted immediately or stored in liquid nitrogen. To extract the 
cells, the pellets were resuspended in 0.5% Triton X-100 in water (2 ml per 
cm  3 of cell pellet).  The suspension was aspirated into a 3-ml syringe and 
then repeatedly forced through a  25-gauge needle until only nuclei were 
present. An aliquot of l0 mM Tris/HCl, pH 7.0 containing 3 M  NaCl was 
added to obtain a final concentration of 0.3 M NaCl. The crude extract was 
then centrifuged (50,000 g, 30 min, 4~  and the supernatant was applied 
to a heparin-Sepharose (HS) column (bed volume, 0.5 ml) which had been 
pre-equilibrated at room temperature with 10 mM Tris/HCI, pH 7.0, and 0.6 
M NaCI. The column was extensively washed with 10 mM Tris pH 7.0, 0.6 
M  NaC1,  and sequentially eluted with the same buffer containing 1 M  or 
3 M  NaCI, respectively (40).  The flow  rate was 21  ml/h. Aliquots of the 
fractions eluted were diluted with 0.2% gelatin in calcium and magnesium- 
free PBS, and tested for their abilities to stimulate cell proliferation (16, 39). 
Western Blot Analysis and Radioreceptor Assays 
HS-purified cell extract, pituitary-derived bFGE or molecular weight size 
markers were electrophoresed on  12.5%  SDS-PAGE slab gels and trans- 
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a current of 0.5 mAmp (49). The filters were stained with Ponceau Red and 
the positions of the size markers marked. The stain was removed by exhaus- 
tive washes with 50 mM Tris/HCI pH 7,0, 0.5 M  NaCI (TBS). The filters 
were incubated (1 h, 21~  with 50 mM Tris/HCl pH 7.0, 0.5 M NaCI, and 
0.1%  Tween 20 (TBST), that contained rabbit anti-bFGF polyclonal anti- 
bodies (1 p,g/ml) directed against bFGF (39). Controls were not exposed to 
the antibodies. The filters were washed three times with TBST buffer and 
probed with biotinylated anti-rabbit IgG, The filters were then washed three 
times with TBST and incubated with an alkaline phosphatase-avidin con- 
jugate according to the instructions of the vendor (Vector Laboratories, Inc.). 
The filters were then washed twice with TBS and the alkaline phosphatase 
activity  visualized using 5-bromo-4-chloro-3-indol phosphate and  nitro- 
blue-tetrazolium according to the instructions of the vendor (Kirkegaard & 
Perry Laboratories, Inc.), 
Radioreceptor assays were done using BHK-21 derived cell membranes 
as previously described (28) except that HT-200 filters (Gelman Sciences, 
Inc., Ann Arbor,  MI) were used instead of GA-8 filters. 
DNA Extraction and Southern Hybridization 
DNA from BHK-21 parental and clone 19 cells was extracted essentially as 
described (3). The DNAs were then cut, in separate reactions, with three 
different restriction endonucleases-Hind III, Eco RI, or Bam HI.  12 ~tg 
of cut DNA from each reaction was then loaded onto a 0.8% agarose gel, 
and electrophoresed. The DNA was then transferred to a nitrocellulose filter 
(43) and baked for 2 h at 80~  in vacuo. The filter was prehybridized over- 
night at 42~  in 50 mM sodium phosphate (pH 6.5), 40% formamide, 5￿ 
Denhardt's, 5￿  SSC, and 100 p.g/ml boiled herring sperm DNA. The pre- 
hybridization mix was then removed, and 15 ml of fresh prehybridization 
solution containing 10% dextran sulfate was added. The filters were hybrid- 
ized overnight at 42~  with a bovine bFGF probe (nick-translated, 3  ￿  107 
cpm), consisting of a purified fragment containing 612 bp from the bovine 
bFGF cDNA (extending from an Eco RI linker 103 bp upstream from the 
proposed initiating ATG codon, to an artificial Hind III site created 34 bp 
downstream from the translation termination codon) (1), After the hybrid- 
ization, the filter was washed three times at room temperature in 1x SSC, 
0.1% SDS, t0 min for each wash. The filter was then washed twice (20 min 
per wash) at 50~  in l￿  SSC, 0.1% SDS. The filter was dried and exposed 
to x-ray film at  -80~  with an intensifying screen~ 
RNA Extraction and Northern Hybridization 
Total cellular RNA was isolated from BHK-21  clone 19 cells and from pa- 
rental BHK-21 cells by the method of Chirgwin et al. (4), and analyzed by 
electrophoresis of 20 ~g of total RNA through 1,0% agarose formaldehyde 
gels (26), followed by Northern blot transfer to nitrocellulose (47) and hy- 
bridization to radiolabeled probes. 
The probe for bFGF sequences was the 612 bp Eco Rl-to-Hind  III  se- 
quence of the bovine bFGF cDNA described above for Southern hybridiza- 
tion. The probe for metallothionein was an 800-bp fragment extending from 
a Hind III site upstream of the promoter to an artificial Bam HI site located 
about 30 bp downstream from the transcription start site (added after BAL31 
digestion of the metallothionein gene) (23).  Both probe  fragments were 
purified by electroelution (5). The isolated fragments were labeled to high 
specific activity  using |ct-3~-P]-dCTP  (800  Ci/mmol;  New  England  Nu- 
clear,  Boston,  MA)  by  nick-translation (33).  Nitrocellulose filters  were 
baked after transfer of the RNA, and then prehybridized and hybridized 
in  50%  formamide  with  10%  dextran  sulfate,  according  to  published 
procedures (27). 
Soft Agar Colony Assay 
DF medium (1,5 ml) supplemented with 5% CS and containing 0.6% agar 
was added to 35-mm dishes and allowed to solidify. Cells were trypsinized, 
counted, and suspended in the same medium containing 0.3 % agar at a final 
cell density of 3,000 cells/ml. 1 ml per 35-mm dish was then added. After 
the agar solidified 1 mt of DF medium containing 5% CS, 40 ~tM ZnSO4 
with or without bFGF  (final concentration 500 pg/ml) was added to the 
dishes, The cultures were maintained in humidified incubators (37~  in a 
5% COj95%  air environment for 7-9 d and bFGF (500 pg/ml) was added 
where indicated every other day,  Viable colonies were stained by the addi- 
tion of 10 ~tl per dish of MTT stain (10 mg/ml) followed by incubation over- 
night at 37~  Stained colonies with a  diameter exceeding 100 ~tm were 
counted using a Bausch and Lomb stereo dissecting microscope at a 10-fold 
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Figure  1.  Schematic diagram of the pbFGF  expression vector. 
magnification, and photographed using a  Nikon Diaphot inverted micro- 
scope at a  100-fold  magnification. 
Results 
Expression of  a Human bFGF  cDNA in BHK-21 Cells 
An expression vector (pbFGF) was constructed in which the 
human metallothionein IIA gene promoter (23)  was placed 
between the SV-40 enhancer and a cDNA sequence encoding 
the proposed 155 amino acid precursor form of human bFGF 
(2). A short, growth hormone gene-derived polyadenylation 
signal was then attached at the 3' end of the bFGF coding se- 
quence, and the resulting construct was ligated into pUC8 to 
create the plasmid pbFGF (Fig.  1). This plasmid was intro- 
duced by the calcium phosphate transfection method (51) into 
BHK-21 cells  along  with  two  other  plasmids:  pSV2neo, 
which contains  the  sequences  coding  for  aminoglycosyl- 
phosphotransferase II; and pUC9-MT18,  which contains the 
human metallothionein IIA gene. The pUC9-MT18  plasmid 
was used to enable an eventual cadmium selection for high 
producers (i.e., cells expressing the products of the trans- 
fected DNA sequences at high levels), if necessary. Control 
cultures were transfected with plasmids pSV2neo and pUC9- 
MT18 only. Clones resistant to 570  lag/ml of the antibiotic 
Geneticin (G-418) were selected and expanded as described 
in Materials and Methods. 
Control cells transfected only with pSV2neo and pUC9- 
MT18, as well as cells transfected additionally with pbFGF, 
proliferated  actively  in  serum-supplemented  medium.  In 
contrast,  when  tested  under  serum-free  conditions,  only 
cells transfected with pbFGF could proliferate. Those cells 
were then further cloned by seeding at limiting dilution into 
96-well cluster plates in the presence of serum-supplemented 
DF medium. After 10 d in culture, 30%  of the wells con- 
tained actively proliferating clones, which were then tryp- 
sinized  and  further selected  for  their ability  to  grow  on 
gelatinized  dishes  containing  DF  medium  supplemented 
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rental BHK-21 and BHK-21 clone 
19 cells. Genomic DNA was ex- 
tracted  from  parental  BHK-21 
cells (lanes 1, 3, 5) or from BHK- 
21 clone 19 cells (lanes 2, 4, 6) as 
described in Materials and Meth- 
ods.  The  DNA  was  cut  with 
the restriction enzymes Hind III 
(lanes 1 and 2), Eco RI (lanes 3 
and 4), and Bam HI (lanes 5 and 
6).  12 lag of cut DNA from each 
reaction  were  then  loaded  on 
a 0.8% agarose  gel,  electropho- 
resed,  transferred  to  nitrocellu- 
lose  paper,  probed  with  a  nick 
translated  bFGF probe,  and  vi- 
sualized  by  autoradiography  as 
described in Materials and Meth- 
ods. (B) Northern blots of paren- 
tal BHK-21 and BHK-21 clone 19 
cells. Total cellular RNA was pre- 
pared from parental (lanes 1 and 
3)  or  clone  19  BHK-21 cells 
(lanes 2 and 4), and 20 lag were 
loaded per lane on a 1% agarose- 
formaldehyde  gel,  as  described 
in  Materials  and  Methods. The 
RNA was transferred to nitrocel- 
lulose,  hybridized  with  a  bFGF 
nick-translated cDNA probe  (lanes 
1 and 2),  or with a metallothio- 
nein nick-translated probe (lanes 
3 and 4), and visualized by auto- 
radiography as described  in Ma- 
terials and Methods. 
with transferrin,  and HDL instead of serum.  The medium 
also contained 20 I.tM ZnSO4, to induce the metallothionein 
IIA promoter. Under these conditions, neither parental cells 
nor control transfected cells can proliferate. After 6 d in cul- 
ture, 45% of the gelatinized wells contained actively prolif- 
erating  cells.  The  conditioned  medium  from all  of these 
clones was mitogenic when tested on ACE cells, and all cell 
lysates contained immunoreactive bFGF-like material (data 
not shown). One of the proliferating clones (clone  19) was 
selected for further detailed studies of bFGF expression. 
When the genomic DNA from BHK-21 clone 19 cells was 
analyzed  by  Southern  blot,  at  least  two  copies  of bFGF 
cDNA appeared to be integrated in the genome (Fig.  2 A, 
lanes 2 and 4). These copies were distinct from the endoge- 
nous hamster bFGF gene, which was easily detected in pa- 
rental genomic DNA as three separate bands that presum- 
ably correspond to the three bFGF exons (Fig. 2 A, lanes 1 
and 3)  (2). 
Northern analysis reveals the presence of two RNA tran- 
scripts of ~0.6 and 4.3 kb, respectively, in BHK-21 clone 19 
cells (Fig.  2  B,  lane 2).  The 0.6-kb  mRNA was predicted 
from the structure of the pbFGF plasmid (Fig.  1). The origin 
of the 4.3-kb transcript has not been determined, but could 
represent transcription  initiating from an endogenous pro- 
moter located close to one of the copies of the pbFGF se- 
quences,  or readthrough  of the  growth hormone gene-de- 
rived polyadenylation signal. The two transcripts seen differ 
in size from the endogenous bFGF mRNAs (7 and 3.7 kb, 
respectively),  which  can  readily  be  detected  in  bovine, 
mouse,  or  human  cell  types that  express  the  endogenous 
bFGF gene (1, 32, 38, 39, 40). The two RNA transcripts also 
hybridized to the metallothionein probe (Fig. 2 B,  lane 4), 
indicating  that  they  were  derived  from  the  pbFGF  DNA 
which was introduced into the cells. The RNA co-migrating 
with the 28S ribosomal marker in Fig. 2 B, lanes 3 and 4 pre- 
sumably  represents the  mRNA of an endogenous hamster 
metallothionein gene.  In contrast,  parental cells (Fig.  2  B, 
lane 1), or control cells transfected with pSV2neo and pUC9- 
MTI8 (not shown), did not contain detectable levels of bFGF 
mRNA transcripts. 
Transfected BHK-21 Cells Contain 
Biologically Active bFGF 
To assess whether pbFGF transfected cells produce bioactive 
bFGE  cell  extracts  from 2  x  lO  s BHK-21  clone  19  cells 
were partially purified by HS affinity chromatography. The 
eluted fractions were then examined for their ability to stimu- 
late the proliferation of adrenal  cortex-derived endothelial 
cells, a cell type that specifically responds to FGF (Fig. 3 A). 
Most of the  proteins  (>99%)  present  in  the crude extract 
were either not retained by the HS column or were eluted in 
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Figure 3.  (A) Heparin-Sepharose affinity chromatography of extracts prepared from BHK-21 clone 19 cells. Extracts from 2  x  108 cells 
were prepared as described in Materials and Methods, and applied to an HS affinity column.  Material bound to the column was eluted 
stepwise with increasing concentrations of NaCI, as indicated. Aliquots of the fractions eluted were then examined for the presence of 
bFGF-like material. For determination of bFGF-like bioactivity, aliquots of the fractions were diluted 10-fold in PBS/0.2%  gelatin and 
10 Ixl of the dilutions were added every other day to ACE cells that had been seeded at a density of 1 x  104 cells per 35-mm dish. Addi- 
tional dishes received either 0.2% gelatin only (no additions) or pituitary-derived bFGF (1 ng/ml). The cells were counted after 5 d. Cell 
numbers represent the means of triplicate determinations. Variation between replicates was <5 %. (B) Effect of increasing concentrations 
of HS purified BHK-21 clone 19 cell extract on the proliferation of ACE cells. Increasing concentrations of bFGF-like material purified 
from BHK-21  clone 19 cells (fraction 27 of A) (o) or of pituitary-derived bFGF (o) were added every other day to ACE cells that had 
been seeded at a density of 1  x  104 cells per 35-mm dish. Each dish contained 2 ml of medium. The cells were counted in a Coulter 
Counter after 5 d in culture. Values represent the means of duplicate determinations. Variation between replicates was <5 %. (C) Examina- 
tion of HS purified clone 19 cell extracts by radioreceptor assay.  ~25I-bFGF  (0.3 ng/tube, 2  x  105 cpm/ng) and BHK-21 cell membranes 
(16 lxg protein/tube) were incubated with increasing concentrations of HS purified BHK-21 clone 19 cell (A, fraction 27) extract that was 
dialyzed overnight against binding buffer at 4~  (o), or with increasing concentrations of pituitary-derived bFGF (o) (28).  ~25I-bFGF 
binding was then determined as described in Materials and Methods. In the presence of ~25I-bFGF  alone,  1.3  ￿  104 cpm were bound to 
the membranes. Nonspecific binding in the presence of 20 rig/tube pituitary bFGF was 2.6  x  103 cpm, and was subtracted from the ex- 
perimental values. Binding is expressed as percent of specific binding in the absence of binding inhibitors (control). Values are the means 
of triplicate determinations. Variation between replicates was <10%. 
the 0.6 M  NaC1 wash.  The unabsorbed material had little if 
any  biological activity.  Elution  of the  columns  with  1  M 
NaCI, however, resulted in the release of bioactive material. 
This  was  unexpected  since at  this  salt concentration  only 
aFGF but not bFGF is reported to elute from HS (11). Subse- 
quent elution with 3 M NaC1 yielded a major bioactive peak, 
which contained most of the total bioactivity present in crude 
extracts. 
The concentration of bFGF-like material present in the 3 
M  NaCI peak fractions, as determined by bioassay, was  12 
rtg/ml (Fig. 3 B). This was confirmed using a radioreceptor 
assay (Fig. 3  C),  which gave similar bFGF cencentrations 
(13 ~tg/ml) in the 3  M  NaCI peak fractions. Total bFGF re- 
covery from 2  x  108 cells was  15  rtg. 
The bFGF molecular species present  in  the  1 and  3  M 
NaC1 eluates were further analyzed by Western blot (Fig. 4). 
In the 1 M  NaCI fractions, only one molecular species with 
an apparent M, of 18 kD reacted with the anti-bFGF anti- 
body (Fig. 4,  lane 2).  This  immunoreactive bFGF species 
therefore has an apparent molecular weight that corresponds 
closely to that of the 155 amino acid bFGF form encoded by 
the bFGF cDNA. In contrast, two immunoreactive molecu- 
lar weight species were present in the 3  M  NaC1  fractions 
(Fig. 4,  lane 1).  One species had an apparent Mr of 18 kD 
and was therefore similar in  size to that found in the  1 M 
Figure 4.  Western blot analy- 
sis of purified BHK-21  clone 
19 cell extract. 30 I.tl of frac- 
tion 27 (Fig. 3 A) (diluted 10- 
fold) (lane/), 30 rtl of purified 
cell extract from  fraction 23 
(Fig. 3 A) (lane 2), or 15 ng of 
pituitary derived bFGF (lane 
3)  were subjected to electro- 
phoresis on an SDS-PAGE gel, 
transferred  to  nitrocellulose 
paper, and incubated with an 
anti-bFGF  polyclonal  anti- 
body (39), as described in Ma- 
terials and Methods. All lanes 
were subsequently exposed to 
goat  anti-rabbit  biotinylated 
antibody. Bound antibody was 
then visualized using an avi- 
din-alkaline phosphatase con- 
jugate as described in  Mate- 
rials and Methods. The protein size markers used were: phosphory- 
lase b (92,000); BSA (66,000);  ovalbumin (45,000);  carbonic anhy- 
drase (31,000);  soybean trypsin inhibitor (21,500);  and lysozyme 
(14,400). 
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Figure 5.  Clone  19 cells, but 
not  parental  BHK-21 cells, 
can proliferate  in serum-free 
medium  supplemented  with 
HDL, transferrin, and ZnSO4. 
2.5  ￿  104 BHK-21 clone  19 
cells (e, zx) or parental BHK- 
21  cells  (o,  [])  were  seeded 
on gelatinized  35-mm dishes 
in DF medium supplemented 
with  HDL,  transferrin,  and 
ZnSO4 as described  in Mate- 
rials and Methods. To half of 
the cultures bFGF (10 ng/ml) 
was  added  every  other  day 
(zx, D).  At  regular  intervals 
triplicate dishes were trypsin- 
ized and cells were counted. 
I  I  I  I  Variation  between  replicates 
2  4  6  8 
Days  was <10%. 
NaC1 fraction, while the other had an apparent Mr of 16 kD, 
which is identical to that of pituitary-derived bFGF (Fig. 4, 
lane 3), a truncated form of bFGF (146 amino acids) lacking 
the first 9  amino acids encoded by the human bFGF gene 
(1, 2,  6,  11). 
pbFGF-transfeeted Cells Are Capable of 
Anchorage-independent Growth, and of 
Autonomous Cell Proliferation at a Rate Similar to 
Parental Cells Treated with bFGF 
Cells from BHK-21 clone 19, in contrast to parental BHK-21 
cells, proliferate when maintained on solid substrate and ex- 
posed to DF medium supplemented with transferrin, ZnSO4, 
and HDL alone. The average doubling time (18 h) during the 
logarithmic growth phase of transfected cells was similar to 
that of parental cells exposed to DF medium supplemented 
with transferrin, HDL, and optimal concentrations of bFGF 
(10 ng/ml) (Fig.  5). 
Parental and transfected BHK-21 cells were analyzed for 
their ability to grow in soft agar. Parental BHK-21 cells (Figs. 
6 and 7 A) or BHK-21 cells transfected with pSV2neo and 
pUC9-MT18 (not shown) did not form colonies when seeded 
in  soft agar and  exposed to  serum-supplemented medium 
even when EGF (10 ng/ml) or TGFB (10 ng/ml) were added. 
In contrast,  in the  presence of exogenous bFGF,  parental 
BHK-21 cells formed colonies, and the colony-forming ef- 
ficiency  was  a  function  of bFGF  concentration  (Fig.  6). 
bFGF was active at concentrations as low as 10 pg/ml, with 
an EDso of 75  pg/ml and saturation at 200 pg/ml (Figs.  6 
and 7 B).  At saturating concentrations colony-forming effi- 
ciency for the parental BHK cells was 67 %. When BHK-21 
clone 19 cells were analyzed for their ability to form colonies 
under similar conditions, even in the absence of exogenous 
bFGF, the colony-forming efficiency was 44 % (Figs.  6 and 
7 C), and at saturating bFGF concentrations, it increased to 
70%  (Figs.  6 and 7 D). 
bFGF  Is Present in Media Conditioned  by 
BHK-21 Clone 19 Cells 
The  possible presence  of bFGF  in  media conditioned  by 
BHK-21 clone 19 cells was suggested by its ability to stimu- 
late the proliferation of ACE cells (Fig.  8 A), while media 
conditioned by control transfected cells did not have any ac- 
tivity.  1 ml of conditioned medium from BHK-21 clone  19 
cells contained '~0.4 ng of bFGF (see Fig. 8). All the mito- 
genic activity in the conditioned medium could be inhibited 
by anti-bFGF directed antibodies (39), and is therefore due 
to bFGF (Fig. 8 B). The amount of bioactive bFGF present 
in conditioned  media was '~1%  of that present in the cell 
layer. The identity of the mitogen present in the conditioned 
medium was further explored by HS affinity chromatogra- 
phy. When the biological activity present in the conditioned 
medium from BHK-21  clone  19 cells was analyzed by HS 
affinity chromatography, a peak of mitogenic activity eluted 
at 3 M NaC1, a salt concentration at which bFGF is expected 
to elute (not shown). 
Protamine Sulfate Inhibits the Autonomous 
Proliferation of  BHK-21 Clone 19 Cells 
Protamine sulfate has been shown in previous studies to be 
anti-angiogenic in vivo (46),  and to prevent the biological 
effect of bFGF by interacting directly with its receptor (30). 
Protamine also inhibits the mitogenic effects of the extracel- 
lular  matrix produced by bovine corneal  endothelial  cells 
(30). In contrast, the mitogenic activity of epidermal growth 
factor is stimulated by protamine sulfate (30).  As shown in 
Fig. 9 A, protamine concentrations that are not cytotoxic for 
BHK-21  cells (42),  inhibited  in a concentration-dependent 
manner the proliferation of BHK-21  clone  19 cells exposed 
to transferrin, ZnSO4,  and HDL-supplemented DF medium. 
The inhibitory effect was maximal at 10 I.tg/ml protamine sul- 
fate.  This result is consistent with the autonomous prolif- 
eration of BHK-21  clone  19  cells being mediated by FGF 
receptors. 
2,000 
1,600  BH~-21 
8  8oo 
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Figure 6. Formation of colonies in soft agar by BHK-21 cells is de- 
pendent upon bFGF even in the presence of serum. 3 x  103 paren- 
tal BHK-21 cells (e) or BHK-21 clone 19 cells (o) were seeded in 
35-mm dishes containing DF medium supplemented with 5% CS, 
antibiotics, ZnSOa (11 IA'I) and agar, as described in Materials and 
Methods.  The  indicated bFGF concentrations  were added every 
other day to the cultures.  After 8 d in culture,  10 I.tl of 10 mg/ml 
MTT was added, and the cultures incubated overnight. The number 
of colonies was determined as described in Materials and Methods. 
The values represent means of triplicate determinations. The bars 
represent the standard deviation from the mean. 
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pearance of soft agar  colonies 
formed by clone 19 and parental 
BHK-21 cells in the presence or 
absence of exogenously  added 
bFGE 3  ￿  103 parentai  BHK- 
21 cells (A and B) or clone 19 
cells (C and D) were seeded in 
35-mm  dishes  containing DF 
medium supplemented with 5 % 
CS, antibiotics,  ZnSO4 (11 paX,  l) 
and agar, as described in Mate- 
rials and Methods.  To half of 
the cultures,  bFGF (0.5 ng/ml) 
was  added  every  other day (B 
and D).  After 9 d  10 ~tl of 10 
mg/ml MTT was added and the 
cultures  incubated  overnight. 
The colonies were photographed 
the next day using a magnifica- 
tion  of  100￿  as  described  in 
Materials  and Methods. 
Is Secretion ofbFGF into the Medium Important  for the 
Autonomous Proliferation of  BHK-21 Clone 19 Cells? 
Since the biological actions of bFGF are mediated by mem- 
brane receptors, it is possible that the bFGF found in the con- 
ditioned medium of pbFGF transfected cells (see Fig. 8) con- 
tributes significantly to their proliferation, while the bFGF 
found associated with the cells contributes little to the mito- 
genic effect.  To investigate the relative contribution of cell- 
associated bFGF versus  released bFGF in supporting the 
proliferation of BHK-21  clone  19  cells,  we  used  two  ex- 
perimental designs. First, we have made use of neutralizing 
anti-bFGF polyclonal antibodies, which in previous studies 
have been shown to neutralize the activity of exogenously 
added bFGF (39).  Second, we have analyzed the prolifera- 
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Figure 8. (A) Effect of conditioned 
medium from control or clone 19 
cells on the proliferation  of ACE 
cells.  BHK-21 clone  19  or con- 
trol cells (transfected with pSV2- 
neo and pUC9-MT18 only) were 
seeded  at  1  x  105  cells/dish  in 
5-cm dishes  and grown  to  con- 
fluence (5  x  106 cells/dish) in se- 
rum-supplemented DF medium. 
Conditioned  medium  was  then 
collected and centrifuged  in a ta- 
ble top centrifuge to remove float- 
ing cells and debris.  Increasing 
volumes of conditioned medium 
were  added  every  other  day  to 
ACE  cells  (1.5  ￿  104  cells  per 
35-mm dish). Cell numbers were 
determined using a Coulter Coun- 
ter after 5 d in culture. Values are 
the means of triplicate determina- 
tions. Variation between replicates 
was <5%.  (B) Anti-bFGF poly- 
clonal antibodies that inhibit the mitogenic effect of bFGF, inhibit the mitogenic activity of medium conditioned by BHK-21 clone 19 cells. 
ACE cells (5  x  103 cells/well), were seeded in 0.5 ml of DME supplemented  with  10% CS in 48-well clusters as described  in Materials 
and Methods. Some cultures did not receive any additions (-) and some received bFGF (+bFGF) (1 ng/ml) in the presence (+Ab) or absence 
of neutralizing anti-bFGF rabbit polyclonal antibodies (10 txg/ml) (39). Other cultures received 75 ~tl of serum-supplemented  DF medium 
that was conditioned by BHK-21 clone 19 cells as described under Fig. 8 A (conditioned  medium). The effect of the conditioned medium 
was analyzed  in the  presence (+Ab) or absence of neutralizing anti-bFGF rabbit polyclonal  antibodies (10 tag/ml) (39).  Conditioned 
medium, anti-bFGF antibodies,  and bFGF were added every other day. The cells were trypsinized and counted after 5 d as described 
in Materials  and Methods.  Values represent the means of triplicate  determinations.  Variation between  replicates  was <10%. 
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Figure 9. (A) The proliferation  of clone 19 cells is inhibited by protamine.  BHK-21 Clone 19 cells (4  ￿  104 cells per gelatinized  35-mm 
dish) were seeded  in DF medium supplemented  with HDL, transferrin,  and ZnSO4 as described in Materials  and Methods.  Increasing 
concentrations of protamine sulfate were added to cultures  every other day as previously  described (30).  Cell  numbers  were determined 
using a Coulter Counter after 4 d in culture.  Values are means of triplicate  determinations.  Variation between  replicates  was <10%.  (B) 
Anti-bFGF polyclonal antibodies that inhibit the mitogenic activity ofbFGF do not affect the proliferation of  BHK-21 clone 19 cells. Parental 
BHK-21 or BHK-21 clone 19 cells (5  ￿  103 cells/gelatinized  well), were seeded in 0.5 ml DF medium supplemented  by HDL, transferrin, 
and ZnSO4 in 48-well clusters  as described in Materials  and Methods.  Parental BHK-21 cells were grown without (-) or with exogenous 
bFGF (1 ng/ml).  BHK-21 clone 19 cells did not receive bFGE Some clusters  received  in addition  10 ~tg/ml of neutralizing  anti-bFGF 
rabbit polyclonal antibodies  (+Ab) (39). Anti-bFGF antibodies  and/or bFGF were added every other day. The cultures were trypsinized 
and cell number determined as described in Materials  and Methods.  Values represent  the means of triplicate  determinations.  Variation 
between replicates  was <10%.  (C) BHK-21 clone 19 cells proliferate  at a maximal rate even when seeded at very low density in serum-free 
medium.  The indicated numbers of BHK-21 clone 19 cells were seeded as described under Materials  and Methods in gelatinized  35-mm 
dishes  in DF medium supplemented  with HDL, transferrin,  and ZnSO4  in the presence  (e) or absence (o) of 5 ng/ml bFGE The cultures 
were trypsinized  and counted in a Coulter Counter after 9 d in culture.  Values are the means of triplicate determinations.  Variation between 
replicates  was <5%. 
tion of BHK-21  clone  19 cells  seeded  at densities  ranging 
from  0.2  to  10  cells/mm  2,  with  or  without  exogenously 
added bFGE 
The results of these two experiments are shown in Fig. 9. 
The addition of neutralizing anti-bFGF polyclonal antibod- 
ies  did  not  result  in  inhibition  of BHK-21  clone  19  cell 
growth, even though the mitogenic activity of exogenously 
added bFGF was completely inhibited by the antibody (Fig. 
9 B).  When the proliferation of BHK-21 clone  19 cells was 
analyzed as a function of cell density, regardless of the den- 
sity at which cells were plated and regardless of whether or 
not they were exposed to exogenous bFGF, cells proliferated 
at the same rate (Fig. 9 C). It therefore seems that the bFGF 
found in the conditioned medium is not required in order for 
BHK-21  clone  19 cells to proliferate. 
Discussion 
Uncontrolled growth factor production by responsive cells 
has been shown in several cases to result in phenotypic trans- 
formation and other changes in cellular behavior. Examples 
include the expression of an introduced TGF~ gene in Rat-1 
fibroblasts (37),  expression of the gene coding for granulo- 
cyte-macrophage colony stimulating factor (GM-CSF) in he- 
matopeoietic cells (25), and expression of either the platelet- 
derived  growth  factor  (PDGF)  B  chain  gene  (9)  or of its 
acquired viral counterpart,  the p28  v-~ gene of Simian Sar- 
coma Virus (20),  in NIH 313 cells. 
Here the hypothesis that inappropriate expression of bFGF 
could also lead to autonomous cell proliferation and the in- 
duction of the transformed phenotype, has been tested by in- 
troducing into BHK-21 ceils a plasmid that directs the high 
level expression of human bFGE BHK-21 cells were chosen 
because they do not express the endogenous bFGF gene, and 
in previous studies, they have been shown to be totally depen- 
dent on exogenous bFGF to proliferate when maintained un- 
der serum-free conditions (31). Finally, exogenous bFGF in- 
duces anchorage-independent  soft agar growth of BHK-21. 
This  effect,  however,  is  transient,  and  cells  revert to their 
normal  phenotype once the  mitogen  is  removed  (data  not 
shown). High level bFGF expression in BHK-21 cells might 
therefore be expected to lead to permanent anchorage-inde- 
pendent  soft agar growth of BHK-21  cells. 
Southern blot analysis demonstrates that in BHK-21 clone 
19 cells,  after transfection,  copies of the transfected bFGF 
gene have been incorporated into the genome of the cells (see 
Fig.  2 A).  That the integrated  foreign bFGF genes are ac- 
tively expressed is indicated by the detection through North- 
ern blot analysis of 0.6- and 4.3-kb RNA transcripts (Fig. 2 
B), which were not seen in the parental BHK-21 cell RNA, 
and  which  differed  in  size  from  those  found  in  bovine, 
mouse,  or human  cells  expressing  the  endogenous  bFGF 
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40). In addition, BHK-21  clone 19 cells contained 2  x  106 
bFGF molecules per cell, while no detectable bioactive FGF 
was found in the parental BHK-21 cells. Two distinct bFGF 
molecular species could be detected by Western blot analy- 
sis: one bFGF molecular species was probably the 155 amino 
acid form bFGF, which is proposed to be the primary trans- 
lation product encoded by the bFGF gene (1, 2), or a form 
missing one amino terminal residue (50), while the other was 
equivalent in size to the 146 amino acid, shorter form found 
in bovine pituitaries (6). This shorter form has been shown 
in previous studies to have an intrinsic biological activity 
similar to that of the larger form (11). Interestingly enough, 
the two forms could be partially separated by HS affinity 
chromatography, with a portion of the longer form having a 
lesser affinity for heparin than the shorter form (Fig. 3). This 
is in agreement with a recent report that showed that a por- 
tion of  the longer form ofbFGF isolated from SK-HEP1 cells 
has a lower affinity for heparin than does the shorter form 
(see Fig.  5 of reference 24). 
The drastic effect of high level expression of bFGF on the 
proliferation of cells that do not normally express the bFGF 
gene is evident from the results presented here. BHK-21 cells 
which, on solid substrate, have an absolute requirement for 
exogenous FGF (or other added growth factor) in order to 
proliferate in serum-free medium, proliferated actively in the 
absence of exogenous growth factor once transfected with 
plasmids carrying the human bFGF coding sequence under 
the control of the SV-40 enhancer and human metallothio- 
nein IIA promoter. Likewise, in soft agar,  transfected cells 
formed colonies, while parental cells required the addition 
of exogenous bFGF in order to do so. Since serum stimulates 
BHK-21  cell proliferation on solid substrate, but not in soft 
agar, these results indicate that serum-derived growth factors 
such as  PDGF cannot support the anchorage-independent 
proliferation of BHK-21  cells. 
Neither acidic nor basic FGF appears to be synthesized 
with  a  conventional  signal  peptide  (1,  21). Some  normal 
diploid  cells that  express the  bFGF gene  and  have been 
shown to contain bFGF protein are still dependent on exoge- 
nous bFGF to proliferate actively in vitro (15), suggesting 
that cell-associated bFGF cannot stimulate growth of normal 
diploid cells in which it is contained. Together, these results 
have suggested that bFGF is processed through the cells in 
a manner different from normal secreted proteins, and there- 
fore through a different cellular compartment than its recep- 
tor. Since cell types sensitive to bFGF have been shown to 
bear specific receptors, on the cell surface, the serum-free 
independent proliferation of the transfected cells could be in 
part mediated by bFGF that is somehow released from these 
cells.  This possibility is supported by the observation that 
medium conditioned by transfected BHK-21 cells does con- 
tain  mitogenic  activity  for  bFGF-responsive  cells.  This 
activity, when analyzed by HS affinity chromatography, be- 
haves in a manner similar to bFGF. Further evidence demon- 
strating that bFGF-like molecules are present in conditioned 
medium can be derived from the ability of anti-bFGF anti- 
bodies to neutralize the mitogenic activity in the medium. 
One should, however, observe that the total bioactivity pres- 
ent in conditioned media was far less (1%) than that present 
within the cells. In addition, neutralizing anti-bFGF poly- 
clonal antibodies could not prevent the proliferation of BHK- 
21 clone 19 cells even though they inhibited the growth of pa- 
rental BHK-21 cells exposed to a saturating concentration of 
bFGF (Fig.  9 B).  Also arguing against a  requirement for 
bFGF to be released in order to trigger cell proliferation, is 
the fact that BHK-21 clone 19 cells seeded at clonal density, 
in the absence of exogenous bFGF,  proliferate as well as 
high density cultures seeded in the absence of bFGF. If cells 
needed to condition their medium with bFGF in order to re- 
spond to it, one would have predicted that clonal density cul- 
tures,  in contrast to high density cultures would have had 
a  lower growth rate,  and that the growth rate would have 
been improved by the addition of exogenous bFGE This was 
clearly not the case (Fig. 9  C). 
Although one could construe from the results discussed 
above that bFGF acts intracellularly, the ability of protamine 
to  inhibit the  proliferation of transfected cells  (Fig.  9  A) 
could reflect its  ability  to  interact directly with  the  FGF 
receptor itself, thereby displacing bound bFGF (30). In the 
case of the results obtained with bFGF antibodies, which in 
previous studies have been shown to neutralize the bioac- 
tivity of soluble bFGF (32, 38, 39), their lack of neutralizing 
effect may reflect their inability to recognize bFGF once it 
is bound to its receptor. This could occur should bFGF as- 
sociate rapidly with cell surface receptors once released, or 
be transported to the cell surface already associated with 
bFGF receptors. Likewise, the results obtained in regard to 
the growth rate of clonal cultures and their lack of exogenous 
bFGF requirement could also reflect either the rapid associa- 
tion of bFGF, once released, to their cell surface receptor, 
or that bFGF receptor complexes are expressed to the cell 
surface. 
We cannot, therefore, exclude the possibility that bFGF 
could have part of its  mitogenic activity mediated through 
events taking place within the cells or on the cell surface, as 
has been proposed for SSV-transformed cells. In that latter 
case, the fact that only a small fraction of the PDGF pro- 
duced by SSV-transformed cells is secreted (36), combined 
with very limited growth inhibition of these cells by antisera 
to PDGF has led to the proposal that the growth factor may 
be able to interact and activate its receptor in an intracetlular 
compartment. Similarly, nontumorigenic hemopoeitic cells 
can be converted into transformed leukemic cells after ex- 
pression of an introduced human GM-CSF gene. The inabil- 
ity of anti-GM-CSF antiserum to prevent transformation im- 
plies that at least part of the GM-CSF receptor interaction 
is intracellular (25). 
In  conclusion,  the  present  study  demonstrates  that 
whether bFGF interacts with its receptor within the cells, or 
at a surface location, it is capable of triggering the autono- 
mous,  anchorage-independent  growth  of a  single  celt  in 
which it is synthesized in high amounts. 
Received  for publication  24 July  1987, and in revised  form  tl  November 
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